Seliger B - Search Results

1

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma.

Schäfer H, Subbarayan K, Massa C, Vaxevanis C, Mueller A, Seliger B. Schäfer H, et al. Among authors: seliger b. J Transl Med. 2023 Sep 20;21(1):643. doi: 10.1186/s12967-023-04476-x. J Transl Med. 2023. PMID: 37730606 Free PMC article.

2

"Tumor immunology meets oncology IV", 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany.

Bukur J, Loeffler D, Massa C, Mueller L, Riemann D, Schmoll HJ, Seliger B. Bukur J, et al. Among authors: seliger b. Cancer Immunol Immunother. 2010 Jun;59(6):955-62. doi: 10.1007/s00262-008-0580-8. Epub 2008 Aug 28. Cancer Immunol Immunother. 2010. PMID: 18751976 Free PMC article. No abstract available.

3

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.

Seliger B, Stoehr R, Handke D, Mueller A, Ferrone S, Wullich B, Tannapfel A, Hofstaedter F, Hartmann A. Seliger B, et al. Cancer Immunol Immunother. 2010 Apr;59(4):529-40. doi: 10.1007/s00262-009-0769-5. Epub 2009 Oct 7. Cancer Immunol Immunother. 2010. PMID: 19820934 Free PMC article.

4

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Seliger B, Handke D, Schabel E, Bukur J, Lichtenfels R, Dammann R. Seliger B, et al. J Transl Med. 2009 Oct 26;7:90. doi: 10.1186/1479-5876-7-90. J Transl Med. 2009. PMID: 19857250 Free PMC article.

5

Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.

Seliger B, Massa C, Rini B, Ko J, Finke J. Seliger B, et al. Trends Mol Med. 2010 Apr;16(4):184-92. doi: 10.1016/j.molmed.2010.02.001. Epub 2010 Mar 19. Trends Mol Med. 2010. PMID: 20304705 Review.

6

"Tumor immunology meets oncology (TIMO) VI" from 7th to 8th of May 2010 in Halle, Germany.

Quandt D, Massa C, Seliger B. Quandt D, et al. Among authors: seliger b. Cancer Immunol Immunother. 2011 Feb;60(2):299-303. doi: 10.1007/s00262-010-0912-3. Epub 2010 Aug 28. Cancer Immunol Immunother. 2011. PMID: 20803010 Free PMC article. No abstract available.

7

Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.

Seliger B, Dressler SP, Massa C, Recktenwald CV, Altenberend F, Bukur J, Marincola FM, Wang E, Stevanovic S, Lichtenfels R. Seliger B, et al. Proteomics. 2011 Jun;11(12):2528-41. doi: 10.1002/pmic.201000486. Epub 2011 May 18. Proteomics. 2011. PMID: 21595034 Free PMC article.

8

Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilities.

Massa C, Seliger B. Massa C, et al. Among authors: seliger b. J Immunol. 2013 Apr 1;190(7):3328-37. doi: 10.4049/jimmunol.1202024. Epub 2013 Feb 27. J Immunol. 2013. PMID: 23447683

9

HER-2/neu mediates oncogenic transformation via altered CREB expression and function.

Steven A, Leisz S, Massa C, Iezzi M, Lattanzio R, Lamolinara A, Bukur J, Müller A, Hiebl B, Holzhausen HJ, Seliger B. Steven A, et al. Among authors: seliger b. Mol Cancer Res. 2013 Nov;11(11):1462-77. doi: 10.1158/1541-7786.MCR-13-0125. Epub 2013 Sep 11. Mol Cancer Res. 2013. PMID: 24025972

10

The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.

Seliger B, Massa C. Seliger B, et al. Front Immunol. 2013 Dec 2;4:419. doi: 10.3389/fimmu.2013.00419. Front Immunol. 2013. PMID: 24348482 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters